2.51 USD
↗ 0.02 (0.60%)LIVE (AS OF 12:50 PM EDT)
Cerus Corp
CERSNASDAQ • USD
Market: OPEN
CERS is currently priced at $2.51. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, CERS trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Sep 11, 2026.
Open?$2.46
High?$2.52
Low?$2.43
Prev. Close?$2.49
Volume?469.3K
Avg. Volume?2.4M
VWAP?$2.48
Rel. Volume?0.20x
Bid / Ask
Bid?$2.48 × 3.0K
Ask?$2.49 × 6.2K
Spread?$0.01
Midpoint?$2.49
Valuation & Ratios
Market Cap?501.8M
Shares Out?201.5M
Float?192.5M
Float %?95.5%
P/E Ratio?N/A
P/B Ratio?7.17
EPS?-$0.03
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
Employees
345
Market Cap
501.8M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
1997-01-31
Address
1220 CONCORD AVENUE
CONCORD, CA 94520
Phone: (925) 288-6000
CONCORD, CA 94520
Phone: (925) 288-6000
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?48
Short Sent.?28
Piotroski F-Score?2/9Weak
Altman Z-Score?-3.57Distress
Confidence?64%Moderate
Short InterestVery High
Short % of Float?9.21%Elevated
Short Interest?17.7M
Days to Cover?10.0
Free Float192.5M
Avg Daily Volume1.8M
Settlement Date2026-08-31
Financial Health
Current Ratio?1.83Adequate
Quick Ratio?1.07Adequate
Cash Ratio?0.21Low
Debt/Equity?0.93Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score75/100
P/E?N/A▾
P/B?7.17FAIR▾
Peers100
S&P26
P/S?2.02CHEAP▾
Peers100
S&P66
P/FCF?N/A▾
EV/EBITDA?8,314.1HIGH▾
Peers100
S&P3
EV/Sales?2.21CHEAP▾
Peers100
S&P72
Returns & Efficiency
ROE?-9.7%WEAK▾
S&P9
ROA?-3.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-1829000
Enterprise Value?$548.7M
Fundamentals ratios updated end of day